Description

Book Synopsis

Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy

Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor.
This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of vir

Table of Contents

List of Contributors, vii

Series Foreword, ix

Preface, xi

Part I Delivery Systems

1 Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors, 3
Vincenzo Cerullo, Kilian Guse, Markus Vähä-Koskela, and Akseli Hemminki

2 Retroviruses for Cancer Therapy, 21
Jiehua Zhou, Yue Ding, John C. Burnett, and John Rossi

3 DNA Plasmids for Non-viral Gene Therapy of Cancer, 39
Amer M. Najjar, Judy S.E. Moyes, and Laurence J.N. Cooper

4 Cancer Therapy with RNAi Delivered by Non-viral Membrane/Core Nanoparticles, 61
Andrew B. Satterlee and Leaf Huang

Part II Targeted Expression

5 Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters, 81
Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang, and Mien-Chie Hung

6 MicroRNAs as Drugs and Drug Targets in Cancer, 97
Hui Ling and George A. Calin

Part III Principles of Clinical Trials in Gene Therapy

7 Regulatory Issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials, 115
Adrian P. Gee and Zhuyong Mei

8 US Regulations Governing Clinical Trials in Gene Therapy, 131
Bambi Grilley

9 Remaining Obstacles to the Success of Cancer Gene Therapy, 151
Malcolm K. Brenner

Index, 157

Cancer Gene Therapy by Viral and Nonviral Vectors

    Product form

    £128.20

    Includes FREE delivery

    RRP £134.95 – you save £6.75 (5%)

    Order before 4pm today for delivery by Fri 10 Jul 2026.

    A Hardback by Malcolm Brenner, Mien-Chie Hung

    10 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Cancer Gene Therapy by Viral and Nonviral Vectors by Malcolm Brenner

      Publisher: John Wiley and Sons Ltd
      Publication Date: 25/07/2014
      ISBN13: 9781118501627, 978-1118501627
      ISBN10: 1118501624

      Description

      Book Synopsis

      Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy

      Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor.
      This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of vir

      Table of Contents

      List of Contributors, vii

      Series Foreword, ix

      Preface, xi

      Part I Delivery Systems

      1 Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors, 3
      Vincenzo Cerullo, Kilian Guse, Markus Vähä-Koskela, and Akseli Hemminki

      2 Retroviruses for Cancer Therapy, 21
      Jiehua Zhou, Yue Ding, John C. Burnett, and John Rossi

      3 DNA Plasmids for Non-viral Gene Therapy of Cancer, 39
      Amer M. Najjar, Judy S.E. Moyes, and Laurence J.N. Cooper

      4 Cancer Therapy with RNAi Delivered by Non-viral Membrane/Core Nanoparticles, 61
      Andrew B. Satterlee and Leaf Huang

      Part II Targeted Expression

      5 Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promoters, 81
      Jennifer L. Hsu, Longfei Huo, Chia-Wei Li, Yi-Hsin Hsu, Yan Wang, and Mien-Chie Hung

      6 MicroRNAs as Drugs and Drug Targets in Cancer, 97
      Hui Ling and George A. Calin

      Part III Principles of Clinical Trials in Gene Therapy

      7 Regulatory Issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials, 115
      Adrian P. Gee and Zhuyong Mei

      8 US Regulations Governing Clinical Trials in Gene Therapy, 131
      Bambi Grilley

      9 Remaining Obstacles to the Success of Cancer Gene Therapy, 151
      Malcolm K. Brenner

      Index, 157

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account